MW
MICHAEL WARD
ALLIANCE FOR AGING RESEARCH · Washington, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
6
6 agencies contacted
Activity
filings by quarter
Works on
Specific issues
-FY25 report language for the Food and Drug Administration -FY25 report language for the Medicare Program -FY25 report language for the Medicare Prescription Payment Plan
-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform
-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program -Utilization management reform in Medicare -Beneficiary access to diabetes management devices -Vaccine access issues
-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -On the creation of an executive branch Office of Caregiver Health -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform
-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program -Utilization management reform in Medicare -Beneficiary access to diabetes management devices -Vaccine access issues -White House Initiative on Womens Health Research
-FY24 report language for the Food and Drug Administration -FY25 report language for the Food and Drug Administration -FY25 report language for the Medicare Program -National Institute of Allergy and Infectious Diseases